TGen finds therapeutic targets for rare cancer in children
RNAi screening used for the first time to study Ewing’s sarcoma August 31 2010
The first study of Ewing’s sarcoma that screened hundreds of genes based on how they affect cell growth has identified two potential anti-cancer drug targets...
TGen’s new link to ASU supercomputer is nation’s fastest
Cox Business LightWave Service connection, enhanced by Obsidian Strategics military technology, accelerates analysis of disease research August 13 2010
A new light-speed computer connection using a military-tested network provides TGen with the nation’s fastest supercomputer link...
TGen provides scientific springboard for Helios Scholars
Eight weeks of summer instruction readies students for scientific careers July 30 2010
Tomorrow’s leaders in science and medicine graduated today from one of the nation’s most advanced summer internship programs at TGen...
TGen Alzheimer’s researcher bikes 200 miles to help increase funding
Dr. Matthew Huentelman conducts Arizona leg of ‘Breakthrough Ride’ July 29 2010
TGen's Dr. Matthew Huentelman will trade test tubes and his lab coat today for a safety helmet and shorts as he bikes 200 miles to help increase funding...
TGen finds protein inhibitor revives chemotherapy for ovarian patients
Discovery provides new hope to cancer patients with few treatment options July 8 2010
Investigators at the Translational Genomics Research Institute (TGen) have discovered a way that may help ovarian cancer patients
Copyright 2009, The Translational Genomics Research Institute (TGen)
445 N. Fifth Street, Phoenix, AZ 85004
phone 602.343.8400 toll free 1.800.642.4432